<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">32502586</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-6787</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>85</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the American Academy of Dermatology</Title>
          <ISOAbbreviation>J Am Acad Dermatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: A systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>1227</StartPage>
          <EndPage>1239</EndPage>
          <MedlinePgn>1227-1239</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaad.2020.05.143</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0190-9622(20)31020-3</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Onychomycosis is the most common nail disorder, often causing physical, emotional, and aesthetic consequences. The effect of both the condition itself and treatment on quality of life has not been well studied.</AbstractText>
          <AbstractText Label="OBJECTIVE">The objectives of this study were to systematically review the available literature describing the effect of onychomycosis and treatment on quality of life.</AbstractText>
          <AbstractText Label="METHODS">We performed a search of the onychomycosis literature published before April 13, 2020. Articles were included in the review if primary data were presented, patient-reported outcome measures were used, and onychomycosis was specifically examined.</AbstractText>
          <AbstractText Label="RESULTS">Thirty studies were included in the final analysis. Poorest quality-of-life scores were associated with women and fingernail involvement. Quality-of-life scores improved from baseline with all treatment types; there were greater improvements reported with oral treatments compared with topical ones.</AbstractText>
          <AbstractText Label="CONCLUSIONS">This review affirms that onychomycosis significantly influences quality of life, warranting effective treatment. All treatments resulted in quality-of-life improvements; however, studies on oral and topical therapies were of higher quality than those evaluating devices. Increased efforts are needed to understand the effect of the disease and therapy as assessed by validated, nail-specific outcome measures that accurately assess patients' cosmetic, physical, and social difficulties.</AbstractText>
          <CopyrightInformation>Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stewart</LastName>
            <ForeName>Claire R</ForeName>
            <Initials>CR</Initials>
            <AffiliationInfo>
              <Affiliation>Weill Cornell Medical College, New York, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Algu</LastName>
            <ForeName>Leah</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kamran</LastName>
            <ForeName>Rakhshan</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leveille</LastName>
            <ForeName>Cameron F</ForeName>
            <Initials>CF</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Plastic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abid</LastName>
            <ForeName>Khizar</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rae</LastName>
            <ForeName>Charlene</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lipner</LastName>
            <ForeName>Shari R</ForeName>
            <Initials>SR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address: shl9032@med.cornell.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>06</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Am Acad Dermatol</MedlineTA>
        <NlmUniqueID>7907132</NlmUniqueID>
        <ISSNLinking>0190-9622</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000935">Antifungal Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000287" MajorTopicYN="N">Administration, Topical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000935" MajorTopicYN="N">Antifungal Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009262" MajorTopicYN="N">Nails</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014009" MajorTopicYN="Y">Onychomycosis</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071066" MajorTopicYN="N">Patient Reported Outcome Measures</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">amorolfine</Keyword>
        <Keyword MajorTopicYN="Y">ciclopirox</Keyword>
        <Keyword MajorTopicYN="Y">debridement</Keyword>
        <Keyword MajorTopicYN="Y">efinaconazole</Keyword>
        <Keyword MajorTopicYN="Y">itraconazole</Keyword>
        <Keyword MajorTopicYN="Y">laser therapy</Keyword>
        <Keyword MajorTopicYN="Y">nail fungus</Keyword>
        <Keyword MajorTopicYN="Y">onychomycosis</Keyword>
        <Keyword MajorTopicYN="Y">patient-reported outcome measures</Keyword>
        <Keyword MajorTopicYN="Y">photodynamic therapy</Keyword>
        <Keyword MajorTopicYN="Y">quality of life</Keyword>
        <Keyword MajorTopicYN="Y">terbinafine</Keyword>
        <Keyword MajorTopicYN="Y">topical therapy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32502586</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jaad.2020.05.143</ArticleId>
        <ArticleId IdType="pii">S0190-9622(20)31020-3</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
